Biomarkers and Precision Oncology Forum shared a post on LinkedIn:
“Precision Therapy Takes Center Stage in Lung Cancer Care.
Session 4 at BPOF 2025 highlights transformative strategies in managing EGFR mutation-positive NSCLC and the latest in biomarker-driven lung cancer therapies.
This session offers cutting-edge insights from regional and global experts committed to reshaping the future of thoracic oncology.
Date: 31 July 2025 | 15:45 – 16:45
Location: Grand Hyatt, Singapore
CME Applied
Register now.”
More posts featuring Precision Oncology.